OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy.
Published in:
Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020236
By:
- Dziewięcka, Ewa;
- Winiarczyk, Mateusz;
- Wiśniowska-Śmiałek, Sylwia;
- Karabinowska-Małocha, Aleksandra;
- Gliniak, Matylda;
- Robak, Jan;
- Kaciczak, Monika;
- Leszek, Przemysław;
- Celińska-Spodar, Małgorzata;
- Dziewięcki, Marcin;
- Rubiś, Paweł
Publication type:
Article
Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy.
Published in:
Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1660, doi. 10.3390/jcm9061660
By:
- Dziewięcka, Ewa;
- Wiśniowska-Śmiałek, Sylwia;
- Karabinowska, Aleksandra;
- Holcman, Katarzyna;
- Gliniak, Matylda;
- Winiarczyk, Mateusz;
- Karapetyan, Arman;
- Kaciczak, Monika;
- Podolec, Piotr;
- Kostkiewicz, Magdalena;
- Hlawaty, Marta;
- Leśniak-Sobelga, Agata;
- Rubiś, Paweł
Publication type:
Article
Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.
Published in:
Cardiology, 2023, v. 148, n. 5, p. 395, doi. 10.1159/000531534
By:
- Dziewięcka, Ewa;
- Winiarczyk, Mateusz;
- Wiśniowska-Śmiałek, Sylwia;
- Karabinowska-Małocha, Aleksandra;
- Robak, Jan;
- Kaciczak, Monika;
- Baranowski, Filip;
- Rubiś, Paweł
Publication type:
Article
First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases.
Published in:
Cardiology Journal, 2020, v. 27, n. 5, p. 639, doi. 10.5603/CJ.a2020.0100
By:
- Dziewięcka, Ewa;
- Winiarczyk, Mateusz;
- Gliniak, Matylda;
- Kaciczak, Monika;
- Wiśniowska-Śmiałek, Sylwia;
- Karabinowska, Aleksandra;
- Holcman, Katarzyna;
- Kostkiewicz, Magdalena;
- Hlawaty, Marta;
- Leśniak-Sobelga, Agata;
- Podolec, Piotr;
- Rubiś, Paweł
Publication type:
Article
Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy.
Published in:
Cells (2073-4409), 2021, v. 10, n. 6, p. 1295, doi. 10.3390/cells10061295
By:
- Rubiś, Paweł;
- Dziewięcka, Ewa;
- Szymańska, Magdalena;
- Banyś, Robert;
- Urbańczyk-Zawadzka, Małgorzata;
- Krupiński, Maciej;
- Mielnik, Małgorzata;
- Wiśniowska-Śmiałek, Sylwia;
- Karabinowska, Aleksandra;
- Podolec, Piotr;
- Winiarczyk, Mateusz;
- Gliniak, Matylda;
- Kaciczak, Monika;
- Robak, Jan;
- Karapetyan, Arman;
- Wypasek, Ewa
Publication type:
Article

Found: 5

Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy.

Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy.

Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.

First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases.

Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy.